Literature DB >> 13740777

[Acceleration of oxidation of drugs during and after treatment with luminal].

H REMMER, M SIEGERT, H W LIEBENSCHUETZ.   

Abstract

Keywords:  DRUGS/metabolism; PHENOBARBITAL/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13740777     DOI： 10.1007/bf01481437

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  11 in total

1.  Blood serum and cerebrospinal fluid levels and renal clearance of phenemal in treated epileptics.

Authors:  P LOUS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1954

2.  [The accelerated decomposition of drugs in the liver microsomes under the effect of luminal].

Authors:  H REMMER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1959

3.  Biochemical pharmacological considerations of zoxazolamine and chlorzoxazone metabolism.

Authors:  A H CONNEY; J J BURNS
Journal:  Ann N Y Acad Sci       Date:  1960-03-30       Impact factor: 5.691

4.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

5.  Biochemical factors in the activation and inactivation of drugs.

Authors:  J AXELROD
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1960

6.  [Activation of detoxication in liver microsome during addiction].

Authors:  H REMMER; B ALSLEBEN
Journal:  Klin Wochenschr       Date:  1958-04-01

7.  The enzymatic metabolism of hexobarbital (evipal).

Authors:  J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-08       Impact factor: 4.030

8.  Phenobarbital: studies of elimination, accumulation, tolerance, and dosage schedules.

Authors:  T C BUTLER; C MAHAFFEE; W J WADDELL
Journal:  J Pharmacol Exp Ther       Date:  1954-08       Impact factor: 4.030

9.  The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-06       Impact factor: 4.030

10.  The metabolic fate of 5-(1-cyclohexen-1-yl)-1, 5-dimethyl barbituric acid (hexobarbital, evipal) and of 5-(1-cyclohexen-1-yl)-5-methyl barbituric acid ("nor-evipal").

Authors:  M T BUSH; T C BUTLER; H L DICKISON
Journal:  J Pharmacol Exp Ther       Date:  1953-05       Impact factor: 4.030
View more
  3 in total

1.  [ACCELERATED DRUG DEGRADATION BY ENZYME INDUCTION IN DOGS AFTER TREATMENT WITH PHENOBARBITAL].

Authors:  H REMMER; M SIEGERT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

2.  [Enzyme induction and increase of endoplasmic reticulum in liver cells during phenobarbital (Luminal) therapy].

Authors:  H REMMER; H J MERKER
Journal:  Klin Wochenschr       Date:  1963-03-15

3.  [The break-down of pentobarbital in hepatic diseases].

Authors:  H F von Oldershausen; H Held; H Remmer
Journal:  Klin Wochenschr       Date:  1970-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.